TGA Approval

ATROVENT NASAL ipratropium bromide monohydrate 22 microgram/actuation spray solution (53362)

ARTG ID

53362

ARTG Name

ATROVENT NASAL ipratropium bromide monohydrate 22 microgram/actuation spray solution

Sponsor

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

ARTG Date

August 30, 1995

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

SANOFI-AVENTIS HEALTHCARE PTY LTD

https://medical-cdn.nocode.com/drug_tga/fb37d2a90b5d905d014f0f75d24a77eb.pdf

Ingredient Name

ipratropium bromide

Empowering clinical research with data-driven insights and AI-powered tools.

ATROVENT NASAL ipratropium bromide monohydrate 22 microgram/actuation spray solution (53362) - TGA 批准文号 | MedPath